A 28-year-old female with a history of celiac disease presents with marked pallor, abdominal distension, a rash consistent with dermatitis herpetiformis, and anemia despite adherence to a gluten-free diet. Laboratory findings indicate hyponatremia, hypoalbuminemia, and elevated CRP. Which of the following nursing interventions is most critical to address her current clinical condition?

B) Collaborate with the healthcare team to prepare the patient for an immediate endoscopic evaluation.

A) Initiate a referral for nutritional counseling to ensure strict adherence to a gluten-free diet.

B) Collaborate with the healthcare team to prepare the patient for an immediate endoscopic evaluation.

C) Administer intravenous iron supplementation to correct her iron deficiency anemia.

D) Monitor the patient's fluid and electrolyte balance closely to manage her hyponatremia.

A 28-year-old female with a history of celiac disease presents with marked pallor, abdominal distension, and a rash consistent with dermatitis herpetiformis. Laboratory results reveal anemia, hyponatremia, hypoalbuminemia, and elevated CRP. Despite adherence to a gluten-free diet, symptoms persist. Based on these findings, what is the most appropriate nursing intervention to prioritize in collaboration with the healthcare team?

B) Initiate a detailed dietary review to identify potential gluten exposure.

A) Administer intravenous iron supplements to address her anemia.

B) Initiate a detailed dietary review to identify potential gluten exposure.

C) Prepare the patient for an urgent endoscopic evaluation to assess for refractory celiac disease.

D) Educate the patient on the importance of increasing dietary sodium and protein intake.

A patient with refractory celiac disease presents with significant villous atrophy, elevated tissue transglutaminase IgA antibodies, and severe anemia despite a strict gluten-free diet. Given these findings, which nursing intervention would be the priority to address the patient's current clinical manifestations?

A) Administer intravenous iron supplementation to address anemia.

B) Initiate discussions about immunosuppressive therapy with the gastroenterology team.

C) Monitor for potential complications of lymphoproliferative disorders following CT scan results.

D) Implement a high-calorie, gluten-free diet to improve nutritional status.

A patient with refractory celiac disease and a strict gluten-free diet presents with significant villous atrophy, elevated tissue transglutaminase IgA antibodies, and worsening anemia. The healthcare team is considering immunosuppressive therapy, but before proceeding, which nursing intervention is most critical to prioritize?

C) Collaborate with the multidisciplinary team to conduct further diagnostic testing for additional autoimmune conditions.

A) Initiate an immediate blood transfusion to address the declining hemoglobin levels.

B) Educate the patient on the importance of strict dietary adherence to prevent further intestinal damage.

C) Collaborate with the multidisciplinary team to conduct further diagnostic testing for additional autoimmune conditions.

D) Monitor the patient’s vital signs closely and prepare for potential fluid resuscitation.

A patient with refractory celiac disease and newly diagnosed multiple myeloma presents with worsening anemia and persistent tachycardia. The interdisciplinary team is considering initiating chemotherapy. Which nursing intervention is most critical in prioritizing this patient's immediate care needs?

C) Administer supplemental oxygen to manage tachycardia.

A) Initiate a gluten-free diet to manage celiac symptoms.

B) Prepare the patient for chemotherapy administration.

C) Administer supplemental oxygen to manage tachycardia.

D) Monitor and manage potential chemotherapy side effects.

A patient with refractory celiac disease and a new diagnosis of multiple myeloma presents with mild ascites and worsening anemia. Which nursing intervention is the most critical in managing this patient's care?

B) Monitor vital signs closely and assess for signs of bleeding or infection.

A) Initiate a gluten-free diet education session to ensure strict dietary adherence.

B) Monitor vital signs closely and assess for signs of bleeding or infection.

C) Prepare the patient for chemotherapy administration and manage potential side effects.

D) Facilitate a multidisciplinary meeting to coordinate comprehensive care planning.

A nurse is preparing to administer a blood transfusion to a patient with multiple myeloma who exhibits anemia with a hemoglobin level of 7.2 g/dL, hypotension, and elevated heart rate. Which of the following actions should the nurse prioritize to ensure patient safety during the transfusion process?

B) Verify the patient's identity and blood type with two nurses before starting the transfusion.

A) Pre-medicate the patient with antihistamines and acetaminophen to prevent transfusion reactions.

B) Verify the patient's identity and blood type with two nurses before starting the transfusion.

C) Monitor the patient's vital signs every hour during the transfusion for any changes.

D) Initiate the transfusion at the maximum rate to quickly improve the patient's hemodynamic status.

A patient with multiple myeloma is about to begin a chemotherapy regimen including bortezomib, lenalidomide, and dexamethasone. Her recent assessments show hypotension, tachycardia, mild dyspnea, anemia, and slightly elevated creatinine levels. Which nursing intervention is the priority to address before initiating chemotherapy?

B) Initiate transfusion of packed red blood cells to manage anemia.

A) Administer antiemetics to prevent nausea and vomiting.

B) Initiate transfusion of packed red blood cells to manage anemia.

C) Arrange for a renal ultrasound to assess kidney function.

D) Educate the patient about potential side effects of chemotherapy.

A patient with multiple myeloma and suspected amyloidosis is experiencing worsening dyspnea, peripheral edema, and jugular venous distension after receiving packed red blood cells and intravenous fluids. An echocardiogram shows a reduced left ventricular ejection fraction. Which nursing action is most appropriate to address the patient's immediate hemodynamic instability?

B) Administer a diuretic as prescribed to manage fluid overload.

A) Increase the rate of intravenous fluids to maintain blood pressure.

B) Administer a diuretic as prescribed to manage fluid overload.

C) Encourage the patient to increase oral fluid intake.

D) Position the patient in Trendelenburg to improve venous return.

A patient with a history of multiple myeloma and amyloidosis presents with reduced left ventricular ejection fraction, dyspnea, peripheral edema, and elevated creatinine levels after receiving packed red blood cells and intravenous fluids. Which nursing intervention should be prioritized to address the current clinical findings and prevent further complications?

A) Administer diuretics as prescribed to reduce fluid overload and monitor for changes in renal function.

B) Increase intravenous fluid rate to improve renal perfusion and monitor for signs of fluid overload.

C) Encourage a high-protein diet to support renal function and manage the effects of multiple myeloma.

D) Initiate early mobilization to promote circulation and reduce the risk of venous thromboembolism.

Celiacs disease - Nursing Case Study

Pathophysiology

• Primary mechanism: Celiac disease is an autoimmune disorder triggered by the ingestion of gluten, a protein found in wheat, barley, and rye. The presence of gluten peptides leads to inappropriate activation of the immune system, targeting the small intestine's mucosa.

• Secondary mechanism: The immune response involves the interaction between gluten-derived peptides and tissue transglutaminase enzyme (tTG), forming complexes that are presented by HLA-DQ2 or HLA-DQ8 molecules. This presentation activates CD4+ T cells, resulting in the release of pro-inflammatory cytokines and subsequent villous atrophy, crypt hyperplasia, and infiltration of lymphocytes.

• Key complication: Severe malabsorption arises due to the destruction of intestinal villi, leading to deficiencies in essential nutrients such as iron, calcium, and vitamins A, D, E, and K, potentially causing anemia, osteoporosis, and neurological disturbances.

Patient Profile

Demographics:

28-year-old female, software engineer

History:

• Key past medical history: Diagnosed with Celiac disease at age 10, recurrent episodes of malabsorption, osteoporosis, and dermatitis herpetiformis. History of type 1 diabetes and autoimmune thyroiditis.

• Current medications: Levothyroxine, insulin, calcium and vitamin D supplements, gluten-free multivitamin, loperamide as needed

• Allergies: Penicillin, seafood

Current Presentation:

• Chief complaint: Severe abdominal pain and persistent diarrhea

• Key symptoms: Unintentional weight loss, chronic fatigue, bloating, skin rash, joint pain, and anemia

• Vital signs: Blood pressure 90/60 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 101.3°F, oxygen saturation 94% on room air

Section 1

Initial Assessment Findings:

Upon further evaluation of the 28-year-old female patient, the nursing team conducted a thorough physical and laboratory assessment to better understand her current clinical status. The physical examination revealed marked pallor, pronounced abdominal distension, and a prominent rash consistent with dermatitis herpetiformis over the elbows and knees. Her abdomen was tender to palpation, particularly in the lower quadrants, with hyperactive bowel sounds indicating increased intestinal motility. Despite her history of a strict gluten-free diet, there were signs suggestive of continued gluten exposure or another underlying gastrointestinal issue exacerbating her symptoms.

Laboratory results provided additional critical insights into her condition. Her hemoglobin level was found to be significantly low at 8.5 g/dL, indicating worsening anemia likely due to iron deficiency from chronic malabsorption. Serum ferritin was also reduced at 10 ng/mL, supporting this finding. Her electrolyte panel showed hyponatremia with a sodium level of 128 mmol/L, and hypoalbuminemia with an albumin level of 2.8 g/dL, reflecting her malabsorptive state and potential protein-losing enteropathy. Additionally, her C-reactive protein (CRP) was elevated at 45 mg/L, suggesting an inflammatory process. The patient's thyroid function tests were stable, indicating that her autoimmune thyroiditis was well-managed with her current levothyroxine regimen.

These assessment findings suggest a complex interplay of celiac disease exacerbation, potential inadvertent gluten exposure, and possible additional gastrointestinal pathology. The presence of persistent severe symptoms despite dietary compliance raises concerns about refractory celiac disease or another autoimmune process. The next step in her care will involve a multidisciplinary approach, including gastroenterology consultation for potential endoscopic evaluation, further dietary review, and possible immunosuppressive therapy to manage her refractory symptoms and prevent further complications.

Section 2

As the multidisciplinary team pursued further diagnostic evaluations, an urgent gastroenterology consultation was arranged. The gastroenterologist recommended an endoscopic examination to assess for villous atrophy and any other potential structural abnormalities in the gastrointestinal tract. The procedure revealed significant villous blunting and crypt hyperplasia in the duodenum, consistent with severe mucosal damage often seen in refractory celiac disease. Additionally, random biopsies from the small intestine showed an increased intraepithelial lymphocyte count, which raised suspicion for Type I refractory celiac disease. This finding was particularly concerning given her strict adherence to a gluten-free diet, necessitating further exploration of potential underlying drivers of her symptoms.

In conjunction with the endoscopic findings, the patient's serological tests were reevaluated. Her tissue transglutaminase IgA antibodies remained elevated at 30 U/mL, reinforcing the notion of ongoing intestinal inflammation. Given the mounting evidence of refractory celiac disease, the team initiated a discussion about immunosuppressive therapy to manage her condition. Nonetheless, before proceeding with this intervention, the possibility of additional autoimmune conditions or malignancy was considered, prompting a CT scan of the abdomen and pelvis to rule out lymphoproliferative disorders or other significant pathology.

The patient’s status was closely monitored during this period, with particular attention to her hemodynamic stability and nutritional status. Despite supportive care, including intravenous iron supplementation and dietary adjustments under the guidance of a dietitian, her hemoglobin level further declined to 7.9 g/dL. Her vital signs showed a persistent mild tachycardia at 102 bpm, with a blood pressure of 95/60 mmHg, suggesting a need for more aggressive management of her anemia and potential fluid imbalances. These developments highlighted the urgency in addressing her refractory symptoms and optimizing her treatment plan to prevent further deterioration and address the underlying disease processes effectively.

Section 3

As the patient's condition continued to evolve, the team received new diagnostic results from the CT scan of the abdomen and pelvis. The imaging revealed mildly enlarged mesenteric lymph nodes, which raised concern for a possible lymphoproliferative disorder. This finding compounded the complexity of her case, especially given her refractory celiac disease and strict adherence to a gluten-free diet. Additionally, the scan noted mild ascites, which was unexpected and prompted further evaluation to determine its etiology. These new findings necessitated a multidisciplinary discussion regarding the likelihood of an underlying malignancy or another autoimmune condition contributing to her clinical presentation.

In light of the CT scan results, a bone marrow biopsy was performed to assess for any hematological abnormalities that could explain her worsening anemia and lymphadenopathy. The biopsy was notable for hypercellularity with an increase in plasma cells, suggestive of a possible plasma cell dyscrasia. Concurrently, serum protein electrophoresis was conducted and revealed an M-spike, further supporting a diagnosis of monoclonal gammopathy. These results pointed towards a potential diagnosis of multiple myeloma, a complication that required immediate attention and a shift in the patient's management plan.

The emerging diagnosis of multiple myeloma added a new layer of complexity to the patient's care, necessitating a reevaluation of her treatment strategy. The interdisciplinary team, which now included a hematologist, debated the initiation of chemotherapy alongside continued management of her refractory celiac symptoms. The patient's declining hemoglobin levels and persistent tachycardia underscored the urgency of initiating appropriate interventions to address both her hematological and gastrointestinal challenges. As the team prepared to discuss these findings and treatment options with the patient, they remained acutely aware of the need for a nuanced approach that balanced aggressive treatment with careful monitoring of potential side effects.

Section 4

As the multidisciplinary team deliberated on the patient's complex condition, they decided to initiate a chemotherapy regimen tailored to her emerging diagnosis of multiple myeloma. The initial plan included a combination of bortezomib, lenalidomide, and dexamethasone, chosen for their efficacy in treating plasma cell dyscrasias while considering the patient's other health challenges. Prior to commencing treatment, a comprehensive assessment was conducted to establish a baseline and identify any immediate concerns that might warrant additional intervention.

Upon reassessment, the patient exhibited signs of further clinical deterioration. Her vital signs were concerning: blood pressure had dropped to 95/60 mmHg, her heart rate remained elevated at 110 beats per minute, and she continued to experience mild dyspnea. Laboratory results were equally worrisome; hemoglobin had decreased further to 7.2 g/dL, prompting consideration of a transfusion to stabilize her condition before starting chemotherapy. Renal function tests showed a slight increase in creatinine levels at 1.6 mg/dL, raising suspicions of renal involvement potentially secondary to multiple myeloma or dehydration.

These findings necessitated immediate interventions to prepare her for the impending chemotherapy. The team prioritized stabilizing her hemodynamics and addressing her anemia, opting for the administration of packed red blood cells and intravenous fluids to ensure adequate perfusion and renal protection. The patient's nutritional status, already compromised by her refractory celiac disease, prompted a consultation with a dietitian to optimize her caloric and protein intake, essential for withstanding the rigors of chemotherapy. As the team implemented these critical measures, they remained vigilant for any new complications, understanding that the patient's journey was fraught with potential challenges that demanded relentless clinical vigilance and adaptive strategies.

Section 5

As the multidisciplinary team implemented the initial interventions, they observed the patient closely for any changes in her condition. Within 24 hours, her response to the administration of packed red blood cells and intravenous fluids was assessed. Her hemoglobin levels showed a modest improvement, rising to 8.5 g/dL, suggesting a positive response to the transfusion. However, her blood pressure remained borderline at 100/65 mmHg, and her heart rate persisted at 105 beats per minute, indicating ongoing hemodynamic instability. Despite the fluid resuscitation, the patient's dyspnea worsened, and she began to exhibit signs of peripheral edema and jugular venous distension, raising concerns about potential fluid overload or cardiac involvement.

In parallel, the team received new diagnostic results that provided further insights into the patient's condition. An echocardiogram revealed reduced left ventricular ejection fraction at 40%, suggestive of an emerging cardiomyopathy, possibly exacerbated by the underlying amyloidosis associated with her multiple myeloma. This cardiac complication posed a significant risk, necessitating an immediate reevaluation of her fluid management and consideration of cardioprotective strategies. Additionally, repeat renal function tests showed a further increase in creatinine to 1.8 mg/dL, reinforcing the suspicion of renal impairment possibly linked to myeloma cast nephropathy or nephrotoxic effects of recent interventions.

Faced with these developments, the team was compelled to refine their treatment approach, balancing the urgency of initiating chemotherapy with the need to stabilize the patient's cardiac and renal status. A cardiologist was consulted to adjust her medication regimen, potentially incorporating diuretics to manage fluid overload without compromising renal perfusion. The nephrology team recommended careful monitoring of her renal function, dietary modifications to limit nephrotoxic risks, and potential adjustments to her chemotherapy protocol to mitigate further renal and cardiac stress. As the patient navigated these challenges, the team remained acutely aware of the precarious balance required to optimize her clinical outcomes, emphasizing the need for ongoing assessment and adaptive management strategies.